Pictet Asset Management (UK)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Pictet Asset Management (UK)’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-96,390	Closed	-$3.63M	–	1887
2021 Q1	$3.63M	Buy	+96,390	New	+$2.4M	﹤0.01%	897
2018 Q2	–	Sell	-417,313	Closed	-$7.17M	–	919
2018 Q1	$7.17M	Sell	417,313 -9,739	-2%	-$190K	0.02%	579
2017 Q4	$9.36M	Sell	427,052 -41,036	-9%	-$1.32M	0.02%	523
2017 Q3	$19.1M	Buy	468,088 +158,863	+51%	+$4.99M	0.05%	371
2017 Q2	$8.74M	Buy	309,225 +65,550	+27%	+$2.05M	0.03%	496
2017 Q1	$8.81M	Buy	243,675 +67,163	+38%	+$2.96M	0.03%	491
2016 Q4	$8.85M	Buy	176,512 +19,793	+13%	+$1.04M	0.03%	469
2016 Q3	$8.23M	Buy	+156,719	New	+$7.48M	0.03%	466

Pictet Asset Management (UK)'s FPRX Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 96,390 shares — an estimated $3.63M sold.

Pictet Asset Management (UK) first reported a position in FPRX in Q3 2016 and held it in 8 quarters. The position peaked at $19.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Pictet Asset Management (UK) reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 96,390 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3.63M.
Pictet Asset Management (UK) first reported a position in Five Prime Therapeutics, Inc. in Q3 2016 and held it in 8 quarters.
Pictet Asset Management (UK)'s Five Prime Therapeutics, Inc. position peaked at $19.1M in Q3 2017.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.